TMS@myhealth101.org

Obesity drugs have another superpower: taming inflammation

The blockbuster medications that reduce body weight also reduce inflammation in organs such as the brain, raising hopes that they can treat Parkinson’s and Alzheimer’s diseases. By Mariana Lenharo Immune cells (purple, artificially coloured) can contribute to chronic inflammation.Credit: Steve Gschmeissner/SPL The latest generation of anti-obesity drugs has taken the world by storm, thanks to their effectiveness at […]

Obesity drugs have another superpower: taming inflammation Read More »

Roland Griffiths Reflects on Scientific Investigations of Psychedelic Awakening

https://www.lucid.news/roland-griffiths-reflects-on-scientific-investigations-of-psychedelic-awakening/ BY ANN HARRISON SEPTEMBER 13, 2023 Roland Griffith’s pioneering 2006 study examining the impact of psilocybin on healthy participants opened the door for a new era of scientific inquiry into psychedelics. Together with fellow researchers Bob Jesse, Una McCann and Bill Richards, Griffiths found that psilocybin could spark mystical experiences that had lasting personal meaning and spiritual

Roland Griffiths Reflects on Scientific Investigations of Psychedelic Awakening Read More »

Dementia Linked With Depression in Early and Middle Life

— Can better depression treatment reduce dementia risk? by Judy George, Deputy Managing Editor, MedPage Today July 24, 2023 FROM https://www.medpagetoday.com/neurology/dementia/105607 Depression diagnosed in early, middle, or late life more than doubled the risk for subsequent dementia, a study of 1.4 million people in Denmark showed. The overall hazard of all-cause dementia among people diagnosed with depression

Dementia Linked With Depression in Early and Middle Life Read More »

Do Hormone Treatments for Menopause Increase Dementia Risk?

A new study suggests a link, but experts caution that there’s more to the story.   By Alisha Haridasani Gupta July 10, 2023   A large new study in Denmark suggested that hormone therapy — which women use to manage menopausal symptoms — was associated with an increased risk of developing Alzheimer’s disease and other types of dementia.

Do Hormone Treatments for Menopause Increase Dementia Risk? Read More »

Positive Results from Phase 2a Trial of Psychedelic for Major Depressive Disorder

Jan 25, 2023 Leah Kuntz SPL026 with supportive therapy sees positive results in patients with major depressive disorder. metamorworks/AdobeStock In the first placebo-controlled efficacy study completed to date exploring a short-duration psychedelic for depression, intravenous (IV) N,N-Dimethyltryptamine (DMT)—SPL026—with supportive therapy for the treatment of major depressive disorder (MDD), met the primary endpoint and demonstrated a

Positive Results from Phase 2a Trial of Psychedelic for Major Depressive Disorder Read More »

What are the differences between the Vielight Neuro Alpha and Neuro Gamma devices?

    What are the differences between the Vielight Neuro Alpha and Neuro Gamma devices? The question, “When should I use an alpha frequency and when should I use a gamma frequency?” is not new. In the context of brain photobiomodulation and Vielight products, this question refers to the Vielight Neuro Alpha and Neuro Gamma

What are the differences between the Vielight Neuro Alpha and Neuro Gamma devices? Read More »

Common Viruses Could Be Triggering Alzheimer’s Disease Onset

Published: August 1, 2022 | Molly Campbell Varicella zoster virus (VZV), which commonly causes chickenpox and shingles, activates herpes simplex virus (HSV) from dormancy in neural tissue grown in vitro, which then leads to an increase in plaque deposits and decrease in neural signaling – hallmarks of Alzheimer’s disease. Credit: Tufts University.   A new

Common Viruses Could Be Triggering Alzheimer’s Disease Onset Read More »

Microvascular Dysfunction in COVID-19 Patients: MYSTIC Study

Microvascular Dysfunction in COVID-19 Patients: MYSTIC Study   ALPINE, Utah, Oct. 30, 2020 /PRNewswire/ — Research reveals that COVID-19 patients have severe damage to microcirculation and the endothelial glycocalyx. The data in a newly released study clearly show severe reduction of microcirculation and the endothelial glycocalyx in patients with COVID-19 and underscores the importance of healthy microcirculation

Microvascular Dysfunction in COVID-19 Patients: MYSTIC Study Read More »

Managing Depression as an Inflammatory Condition

Managing Depression as an Inflammatory Condition Lylen Ferris, ND | March 17, 2021 Patients with major depression have been found to exhibit increased peripheral blood inflammatory biomarkers, including inflammatory cytokines. Cytokines have been shown to access the brain and interact with virtually every pathophysiologic domain known to be involved in depression, including neurotransmitter synthesis and metabolism, neuroendocrine function, and neural plasticity. A

Managing Depression as an Inflammatory Condition Read More »